A Phase II Study of the Central European Society of Anticancer-Drug Research (CESAR) Group: Results of an Open-Label Study of Gemcitabine plus Cisplatin with or without Concomitant or Sequential Gefitinib in Patients with Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
|
Author:
|
Miller, Kurt; Morant, Rudolf; Stenzl, Arnulf; Zuna, Ivan; Wirth, Manfred
|
|
Tübinger Autor(en):
|
|
|
Published in:
|
Urologia Internationalis
(2016), Bd.
96,
H.
1,
S.
5-13
|
|
Verlagsangabe:
|
Karger
|
|
Language:
|
English
|
|
Full text:
|
http://dx.doi.org/10.1159/000381589
|
|
ISSN:
|
1423-0399
|
|
DDC Classifikation:
|
610 - Medicine and health
|
|
Dokumentart:
|
Article
|
|
Show full item record
|
